CNBC's "Fast Money"
CNBC
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
Location:
Englewood Cliffs, NJ
Description:
Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.
Twitter:
@CNBCFastMoney
Language:
English
Website:
http://fastmoney.cnbc.com
Email:
fastmoney@cnbc.com
Episodes
Berkshire’s Cash Bulk… And New Data In The Weight Loss Drug Race 11/4/24
11/4/2024
Warren Buffett’s Berkshire Hathaway slashing its positions in a number of big names. So Is the Oracle of Omaha’s recent moves a warning sign for where these stocks are heading? Plus The pill that’s getting easier to swallow… as Viking Therapeutics announces new data on its weight loss drug. The impact on the space, and why the stock reversed course from its initial jump.
Fast Money Disclaimer
Duration:00:43:45
Stocks Jump After Jobs Report… And China’s Big Opportunity 11/1/24
11/1/2024
Stocks climbing on the back of this morning’s weaker-than-expected jobs report. How the unemployment rate is holding up, and what the latest data means for next week’s Fed decision. Plus China stocks in focus, as lawmakers gear up to meet about the country’s next stimulus measures. Why one China expert says this could be a big opportunity for the regulators to restore confidence.
Fast Money Disclaimer
Duration:00:43:51
Apple, Amazon Report Results… And Countdown To The Jobs Report 10/31/24
10/31/2024
Big Tech results continue to filter in… with Apple and Amazon reporting results. How our traders are handling the after-hours moves, and what the latest batch of earnings mean for the broader tech landscape. Plus We’re just days away from the U.S. Presidential Election… and investors are getting the latest read on the economy with tomorrow’s jobs report. How that data could impact voters.
Fast Money Disclaimer
Duration:00:43:50
Big Tech Reports… And Eli Lilly’s Letdown 10/30/24
10/30/2024
Meta and Microsoft in focus, as the big tech names report results. How our traders are handling the moves, and what it means for entire tech trade. Plus Eli Lilly getting hit, as the pharma stock misses estimates and slashes guidance. So are the disappointing results a sign the weight loss drug boom is slimming out?
Fast Money Disclaimer
Duration:00:43:47
Alphabet’s Earnings Results… And The State Of The Presidential Race 10/29/24
10/29/2024
Alphabet on the move after reporting results. How the tech giant fared this quarter, and the impact on the stock. Plus One week to go until the big day, and both candidates are making their final push to the White House. The State of the race, and the latest voting and polling numbers with just 7 days to go.
Fast Money Disclaimer
Duration:00:43:45
The Strength In The Consumer… And Election Proxy Trades 10/28/24
10/28/2024
Retail, airlines, and more consumer-facing spaces already feeling the holiday spirit. How the gains in these spaces could point to a resilient consumer heading into year end. Plus A little over 1 week to go until Election Day, and some stocks are on the move. Where investors are piling into ahead of the big decision.
Fast Money Disclaimer
Duration:00:43:49
Big Tech’s Moment Of Truth As Nvidia Climbs… And Next Move For Rates Description 10/25/24
10/25/2024
Nvidia’s record rally continues, as the AI darling trades near all-time highs, and briefly overtakes Apple in market cap. But are next week’s Big Tech earnings a moment of truth for the AI trade? Plus Rates, Equities, and Inflation ahead of the U.S. Presidential election. How one market trader is positioning ahead of the big night.
Fast Money Disclaimer
Duration:00:43:47
The Most Important Charts In The Market… And Viking’s Weight Loss Surge 10/24/24
10/24/2024
The traders lay out the most important charts in the market right now, as the Dow notches its fourth straight day of losses. Why you need to keep an eye on rates, semis, transports, and more. Plus A biotech boom… as Viking Therapeutics surges as it inches closer to a weight loss drug pill. The cash they have on hand, and why investors believe it can help tip the scales in the obesity drug race.
Fast Money Disclaimer
Duration:00:43:46
Tesla Reports Results… And A Rising Star In The Athleisure Space 10/23/24
10/23/2024
Tesla on the move after reporting results. The numbers out of that quarter, and where the EV maker is heading next. Plus Vuori gaining steam in the athleisure space. Where the CEO sees growth opportunities… and why he says competitors don’t need to fail for them to succeed.
Fast Money Disclaimer
Duration:00:43:46
Asset Moves Ahead Of The Election… And A Tight Boeing Vote On Deck 10/22/24
10/22/2024
Metals, Rates, and Crypto all moving higher as the November elections draws nearer. What one legendary investor is saying about the deficit no matter who wins the presidency. Plus Boeing machinists set to vote on the new wage proposal tomorrow. And the Union President isn’t so sure it’s a done deal. How close he says this vote could be, and what it means for Boeing if the vote falls through.
Fast Money Disclaimer
Duration:00:43:51
CNBC Pro Talks: How Carter Worth knows when it’s time to sell 10/22/24
10/22/2024
CNBC’s Dominic Chu speaks with Carter Braxton Worth, founder and CEO of Worth Charting LLC, to find out how he uses charting alongside his 35 years of Wall Street expertise to decide which stocks are overbought and which could be on the cusp of an upswing. Plus, he takes stock-specific questions from Pro subscribers. CNBC Pro Talks features one-on-one interviews with Wall Street’s top investors, smartest traders and rising stars. CNBC’s Dominic Chu finds out what makes them tick, what makes them money, and how you can follow in their footsteps. CNBC Pro Talks is a monthly interview series that’s part of CNBC’s premium subscription service, CNBC Pro. To hear the full Pro Talk interview—including specific stock picks and investment strategies—listeners can subscribe to [cnbc.com/protalks]
Duration:00:17:47
Yields Head Higher… And AI’s Copyright Issues 10/21/24
10/21/2024
Interest rates heading higher, jumping significantly since the Fed cut its target rate last month. What the surge means for the broader market.. And if the central bank’s next decision will keep yields climbing. Plus AI’s copyright concerns. News outlets going after Perplexity AI, citing copyright issues from the search engine company. How the new suit will impact the entire AI space.
Fast Money Disclaimer
Duration:00:43:47
Market Uncertainties Clearing Up?... And The Longevity Of China’s Rally 10/18/24
10/18/2024
Stocks notching a sixth straight week of gains… as market uncertainties from mideast tensions, to economic worries, to the outcome of the presidential election all seem a bit clearer. What investors are seeing that’s keeping them buying in. Plus China stocks rebounding after a stronger-than-expected GDP report. But one expert is questioning the longevity of the mainland rally. Where he sees the overseas equities heading next.
Fast Money Disclaimer
Duration:00:43:55
Netflix Reports Results… And China’s Housing Pains 10/17/24
10/17/2024
Netflix on the move as the streaming giant reports a beat on the top and bottom line. What the quarter says about where that stock is heading, and how it holds up against the competition. Plus Investors unenthused after China’s latest stimulus efforts. The housing headache they’re facing… and why the measures fell short of expectations.
Fast Money Disclaimer
Duration:00:43:48
Market Rally To Keep Climbing?... And Underwater Auto Loans Growing Larger 10/16/24
10/16/2024
Stocks near record highs, as banks, industrials, and utilities all trade higher. Where investors are seeing opportunity outside of the Mag7. Plus a major warning sign out of the auto space, as underwater car loans grow. The numbers being reported, and what it could mean for the space.
Fast Money Disclaimer
Duration:00:43:51
Chips Trade At Its Peak?... And UnitedHealth Drops After Earnings 10/15/24
10/15/2024
Chip stocks pulling back after a big run up, as ASML plummets after warning of weaker china sales. So has the semi surge seen its peak? Or are there still opportunities hiding in the tech trade? Plus UnitedHealth having its worst day since the start of the pandemic, after posting disappointing profit forecasts for 2025. The rising medical costs impacting that stock.
Fast Money Disclaimer
Duration:00:43:52
Nvidia Nears Records As Stocks Rally To Their Own… And Venture Investor Bradley Tusk On Tech 10/14/24
10/14/2024
Nvidia notching a record close, as the broader indices hit new records of their own. How the AI darling can keep climbing, and if stocks can continue their rally as earnings season gets underway. Plus
Venture investor Bradley Tusk weighs in on tech, crypto, AI regulation, and more. The spaces he’s seeing the most opportunity in, and how markets will fare into year’s end.
Fast Money Disclaimer
Duration:00:43:33
Markets Hit New Highs as Earnings Season Kicks Off, and Tesla Robotaxi Reveal Fails to Impress 10/11/24
10/11/2024
The S&P and Dow both recorded new all-time highs today, and the Nasdaq got as close as its been to a record in three months. The strength coming from big moves higher in JPMorgan and Wells Fargo, which reported this morning. But it wasn’t all good news – Tesla shares sank after the highly anticipated reveal of the Cybercab failed to impress investors.
Fast Money Disclaimer
Duration:00:43:50
CNBC SPECIAL: Ozempic Underworld 10/11/24
10/11/2024
A CNBC investigation into counterfeit weight loss drugs revealed an international illegal marketplace where criminals either brazenly alter the drugs or ship the real product from overseas — what’s known as drug diversion and against federal law. The operations mainly involve phony or illegal versions of Novo Nordisk’s diabetes drug Ozempic and its obesity drug Wegovy as well as Eli Lilly’s Mounjaro and Zepbound. All four drugs are in a class of wildly popular weight loss drugs known as GLP-1s. The skyrocketing demand for the treatments has led to criminal schemes attempting to capitalize on the surge. To view the documentary and read the full article go to https://cnb.cx/3NfQO8V
Duration:00:18:41
Banks Gear Up To Kick Off Earnings Season… And The State Of Commercial Real Estate 10/10/24
10/10/2024
Earnings season is back, and the bank stocks are kicking things off. But after a nice run this year, can results help fuel the financial trade even higher? Plus The State of commercial real estate. How the Fed’s recent rate cut is impacting deals, and if there’s any opportunity left in the space.
Fast Money Disclaimer
Duration:00:43:49